O'Shaughnessy Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$703K Sell
7,607
-3,194
-30% -$321K ﹤0.01% 1357
2025
Q4
$1.1M Buy
10,801
+3,857
+56% +$345K 0.01% 1099
2025
Q3
$434K Buy
+6,944
New +$378K ﹤0.01% 1565
2021
Q4
Sell
-167
Closed -$21K 1715
2021
Q3
$21K Buy
167
+105
+169% +$12.5K ﹤0.01% 1931
2021
Q2
$8K Sell
62
-47
-43% -$6.32K ﹤0.01% 2040
2021
Q1
$17K Buy
109
+16
+17% +$2.42K ﹤0.01% 1669
2020
Q4
$12K Buy
93
+83
+830% +$9.55K ﹤0.01% 1514
2020
Q3
$1K Buy
+10
New +$915 ﹤0.01% 1738

Other funds holding GH

O'Shaughnessy Asset Management's GH Position: Q1 2026 in Review

O'Shaughnessy Asset Management reduced its Guardant Health (GH) stake by 30% in Q1 2026, selling an estimated $321K and leaving 7,607 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

O'Shaughnessy Asset Management first reported a position in GH in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.1M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • O'Shaughnessy Asset Management held 7,607 shares of Guardant Health worth $703K as of Q1 2026.
  • O'Shaughnessy Asset Management sold 3,194 Guardant Health shares in Q1 2026, an estimated $321K.
  • Guardant Health made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #1357 holding.
  • O'Shaughnessy Asset Management first reported a position in Guardant Health in Q3 2020 and has held it in 8 quarters since.
  • O'Shaughnessy Asset Management's Guardant Health position peaked at $1.1M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.